Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
9.2
Year-on-year change in revenue (% decline)Wording
Definitive
How definitive the wording is.Contents of this document
Financial Results PresentationThird quarter of the fiscal year ending October 20264 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales2,557 Millions of yen-9.2%
Operating profit179 Millions of yen+45.3%
Ordinary income174 Millions of yen+36.3%
Net income174 Millions of yen+102.2%
Gross Profit Margin58.9
Operating profit margin7
Results for the three months of the current quarter
Net Sales
858 Millions of yen-2.7%
Operating profit
98 Millions of yen+111.3%
Ordinary income
100 Millions of yen+163.2%
Net income
130 Millions of yen+407.2%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Impact of the transition to standalone financial statements following the absorption-type merger-49 Millions of yen
- Decline following the previous year's higher-than-expected cosmetics OEM sales-31 Millions of yen
- Other factors-24 Millions of yen
- Other factors contributing to the increase15 Millions of yen
New initiatives
- Initiatives related to the Wellness & Longevity business
- Initiatives related to ASC, Signalift, PAJUU, CPC and other businesses
- Marketing initiatives including web, advertising and SEO
Unit price and quantity metricsThese figures show sales broken down by price and volume.
DescriptionA KPI table combining volume and unit-price metrics is provided
FiguresMultiple figures for customer counts, unit prices and other metrics are provided
Segment results
- Contract Processing ServicesChange in amount158
- Medical Equipment SalesChange in amount57
- Healthcare Institution Support ServicesChange in amount3
- Cosmetics Sales and Other BusinessesChange in amount-171
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | Third quarter of the fiscal year ending October 2026 |
| Net Sales | 2,557 Millions of yen (YoY -9.2%) |
| Operating profit | 179 Millions of yen (YoY +45.3%) |
| Ordinary income | 174 Millions of yen (YoY +36.3%) |
| Net income | 174 Millions of yen (YoY +102.2%) |
| Gross Profit Margin | 58.9 |
| Operating profit margin | 7 |
| Results for the three months of the current quarter | Net Sales 858 Millions of yen (YoY -2.7%) / Operating profit 98 Millions of yen (YoY +111.3%) / Ordinary income 100 Millions of yen (YoY +163.2%) / Net income 130 Millions of yen (YoY +407.2%) |
| Segment results | Segment Contract Processing Services / Change in amount 158 Millions of yen / yoy_pct 8 Millions of yen, Segment Medical Equipment Sales / Change in amount 57 Millions of yen / yoy_pct 8 Millions of yen, Segment Healthcare Institution Support Services / Change in amount 3 Millions of yen / yoy_pct 3 Millions of yen, Segment Cosmetics Sales and Other Businesses / Change in amount -171 Millions of yen / yoy_pct -42 Millions of yen |
| Breakdown of Factors Affecting the Change | Impact of the transition to standalone financial statements following the absorption-type merger -49 Millions of yen, Decline following the previous year's higher-than-expected cosmetics OEM sales -31 Millions of yen, Other factors -24 Millions of yen, Other factors contributing to the increase 15 Millions of yen |
| Unit price and quantity metrics | Description A KPI table combining volume and unit-price metrics is provided / Figures Multiple figures for customer counts, unit prices and other metrics are provided |
| New initiatives | Initiatives related to the Wellness & Longevity business, Initiatives related to ASC, Signalift, PAJUU, CPC and other businesses, Marketing initiatives including web, advertising and SEO |
Items this document does not state (18)
Selling, general and administrative expensesFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planKey KPIsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited the transition to standalone financial statements following the absorption-type merger, the decline from the previous year's higher cosmetics OEM sales, and declines in the self-pay medical services-focused business, exosome-related business and FatBank. It also reported revenue increases in areas including the hybrid business, contract processing services and medical equipment sales.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.